Restrictive lung disease happens when your lungs can’t fully expand during a breath. Unlike obstructive conditions such as asthma or COPD, where air gets trapped because the airways narrow, restriction means the lungs simply can’t fill with enough air in the first place. The causes fall into two broad groups: problems inside the lungs themselves (intrinsic) and problems outside the lungs that physically prevent them from expanding (extrinsic).
How Restriction Differs From Obstruction
In a healthy breath, your lungs stretch open, air rushes in, and then the chest relaxes to push air back out. Restrictive lung disease disrupts the first part of that process. The lung tissue may be stiff and scarred, the chest wall may be rigid, or the muscles that drive breathing may be too weak to pull the lungs open. In every case, the total volume of air your lungs can hold drops below normal.
Doctors confirm restriction with a breathing test called pulmonary function testing. The key measurement is total lung capacity, which falls below the normal lower limit in restrictive disease. Another hallmark: the ratio of air you can force out in one second compared to your total exhaled breath (FEV1/FVC) stays normal or even high, typically at or above 70% in adults. That’s the opposite of obstructive disease, where that ratio drops because air can’t get out fast enough.
Scarring and Inflammation Inside the Lungs
The most common intrinsic cause is interstitial lung disease, a group of conditions that damage the delicate tissue between your air sacs (alveoli) and the tiny blood vessels surrounding them. When this tissue becomes inflamed or scarred, the lungs stiffen and lose their ability to stretch. The most common form is idiopathic pulmonary fibrosis, where progressive scarring occurs for no identifiable reason. “Idiopathic” simply means the cause is unknown.
When the cause is known, it often traces back to something inhaled or to a systemic illness. Chronic exposure to molds, fungi, bacteria, or even particles from bird feathers and droppings can trigger ongoing inflammation that eventually scars the lungs. Certain medications, including some heart rhythm drugs, antibiotics, and chemotherapy agents, can also damage lung tissue. Radiation therapy to the chest carries the same risk.
Occupational and Environmental Exposures
Workplaces that generate fine dust or fibers are a well-established source of restrictive lung disease. The specific condition depends on what you’re breathing in:
- Asbestos causes asbestosis when tiny fibers lodge deep in the lungs, triggering scarring that worsens over years or decades.
- Silica dust, found in mines, foundries, stone-cutting facilities, and blasting operations, causes silicosis.
- Coal dust causes coal workers’ pneumoconiosis, commonly called black lung disease.
- Cotton, hemp, and flax dust from textile processing causes byssinosis, sometimes called brown lung disease.
These conditions share a pattern: years of exposure lead to chronic inflammation, then irreversible scarring. People working in mining, construction, agriculture, and manufacturing face the highest risk. Tobacco smoke compounds the damage from nearly all occupational exposures.
Autoimmune and Connective Tissue Diseases
Your immune system can turn against your own lung tissue, and several autoimmune conditions carry meaningful risk. Scleroderma is the most aggressive offender: 40 to 60% of people with scleroderma develop interstitial lung disease. The condition causes widespread tissue thickening, and the lungs are a frequent target.
Rheumatoid arthritis affects the lungs in roughly 8 to 10% of cases. Lupus is less likely to cause lung scarring, with only about 2% of patients developing interstitial disease, though it can cause other lung complications. ANCA vasculitis, particularly the form called microscopic polyangiitis, triggers lung disease in about 12% of people affected.
Less common but still significant are anti-synthetase syndrome, which often presents with both muscle inflammation and lung scarring, and dermatomyositis, where certain antibodies can drive a rapidly progressive form of lung disease. Sjögren’s syndrome and mixed connective tissue disease round out the list. Sarcoidosis, while not technically autoimmune, is an inflammatory condition that frequently involves the lungs and can cause restriction through granuloma formation and scarring.
Chest Wall and Skeletal Problems
Even perfectly healthy lung tissue can’t expand if the rib cage won’t allow it. Kyphoscoliosis, a pronounced curvature of the spine, is one of the most common skeletal causes of restriction. Severe curves physically compress the lungs and reduce the space available for expansion. The curvature itself often results from neuromuscular disease, such as muscular dystrophy or the aftereffects of polio.
Obesity is another major extrinsic cause. Excess weight around the chest and abdomen pushes against the diaphragm and restricts how far the lungs can open, particularly when lying down. This is one of the few causes of restrictive lung disease that can be partially or fully reversed.
Pleural conditions also belong in this category. Fluid buildup between the lung and the chest wall (pleural effusion), thickening of the pleural lining, or air trapped in the pleural space (pneumothorax) all prevent the lung from expanding fully, even though the lung tissue itself may be normal.
Neuromuscular Diseases
Breathing is muscular work. Your diaphragm and the muscles between your ribs contract to create the negative pressure that pulls air into your lungs. When neurological or muscular disease weakens those muscles, the lungs can’t inflate properly. The restriction isn’t in the lungs or the chest wall but in the power source driving each breath.
ALS (amyotrophic lateral sclerosis) progressively destroys the nerve cells controlling voluntary muscles, and respiratory failure is often the ultimate cause of death. Muscular dystrophy weakens the respiratory muscles as part of its broader pattern of muscle degeneration. Myasthenia gravis disrupts the signals between nerves and muscles, causing fluctuating weakness that can affect breathing during flare-ups. Multiple sclerosis, cerebral palsy, and Pompe disease also contribute to respiratory restriction in some patients.
The progression in neuromuscular disease follows a predictable path. Shortness of breath first appears during physical activity, then gradually occurs at rest, and ultimately advances to respiratory failure as the muscles weaken further.
How Symptoms Develop Over Time
Regardless of the underlying cause, the hallmark symptom is shortness of breath that gets worse with exertion. In the early stages, you might only notice it during vigorous activity. As the disease progresses, everyday tasks like climbing stairs or walking across a parking lot become difficult. A dry cough is common, particularly in interstitial lung disease, though it rarely produces mucus.
Age plays a role in how quickly symptoms surface. People under 35 with early restrictive disease often have no symptoms at all. Middle-aged adults typically develop noticeable breathlessness, reduced exercise tolerance, and more frequent respiratory infections. Doctors often track symptom severity by asking how far you can walk or how many stairs you can climb before becoming winded, using that as a practical gauge of progression over time.
Chest pain and wheezing can also occur, though they’re less consistent than breathlessness. In neuromuscular forms, you may notice difficulty breathing while lying flat before you notice it while standing, because gravity adds to the workload of already weakened muscles.
Why Identifying the Cause Matters
Treatment for restrictive lung disease depends almost entirely on what’s driving it. Lung scarring from idiopathic pulmonary fibrosis is irreversible, but medications can slow its progression. Restriction from obesity can improve significantly with weight loss. Autoimmune causes may respond to drugs that calm the immune system. Pleural effusions can be drained. Neuromuscular weakness may benefit from breathing support devices that assist the respiratory muscles.
Some causes overlap. A person with rheumatoid arthritis might also have occupational silica exposure, creating two simultaneous pathways to restriction. The breathing test confirms that restriction exists, but imaging, blood work, and sometimes a lung biopsy are needed to pinpoint exactly why the lungs aren’t expanding the way they should.